Brief: Knight Therapeutics announces increase in ownership of Crescita Therapeutics
10/10/2017 13:07
Oct 10 (Reuters) - Knight Therapeutics Inc GUD.TO
* Knight Therapeutics - pursuant to early warning
requirements of national instrument 62-103, co announced
increase in ownership of Crescita Therapeutics
* Knight Therapeutics Inc - now owns aggregate of 2.08
million common shares of crescita representing about 14.9 pct of
outstanding common shares of Crescita
Source text for Eikon: ID:nCCNSH1Qya
Further company coverage: GUD.TO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium